Testing of saliva and serum for HIV in high-risk populations

M. Vall Mayans; J. Casabona; N. Rabella; D. De Miniac; A. Rodés; A. Marco; J. Trabal; C. Trilla

doi:10.1007/BF01690881

Testing of saliva and serum for HIV in high-risk populations

M. Vall Mayans, J. Casabona, N. Rabella, D. De Miniac, A. Rodés, A. Marco, J. Trabal, C. Trilla

Producció científica: Contribució a revista › Article › Recerca › Avaluat per experts

13 Cites (Scopus)

Resum

Paired samples of saliva and serum from 286 highrisk subjects were tested for HIV using two commercial enzyme immunoassays following the same WHO testing strategy supplemented with a Western blot technique. Agreement between HIV testing in both sample types was 98.9 % (95 % confidence interval: 97.7-100). The sensitivity of an EIA (Wellcozyme GACELISA) alone for saliva was 100% (133/133) and the specificity 98.7% (151/153). These results support previous data showing that in some situations saliva might be an effective alternative to serum for HIV testing. © 1995 Springer-Verlag.

Idioma original	Anglès
Pàgines (de-a)	710-713
Revista	European Journal of Clinical Microbiology and Infectious Diseases
Volum	14
DOIs	https://doi.org/10.1007/BF01690881
Estat de la publicació	Publicada - 1 d’ag. 1995

SDG de les Nacions Unides

Aquest resultat contribueix als següents objectius de desenvolupament sostenible.

ODG 3 – Bona salut i benestar

Accés al document

10.1007/BF01690881

Altres arxius i enllaços

https://www.scopus.com/pages/publications/0029091455

Com citar-ho

@article{fb82225189284e0daac62818141dda4b,

title = "Testing of saliva and serum for HIV in high-risk populations",

abstract = "Paired samples of saliva and serum from 286 highrisk subjects were tested for HIV using two commercial enzyme immunoassays following the same WHO testing strategy supplemented with a Western blot technique. Agreement between HIV testing in both sample types was 98.9 \% (95 \% confidence interval: 97.7-100). The sensitivity of an EIA (Wellcozyme GACELISA) alone for saliva was 100\% (133/133) and the specificity 98.7\% (151/153). These results support previous data showing that in some situations saliva might be an effective alternative to serum for HIV testing. {\textcopyright} 1995 Springer-Verlag.",

author = "Mayans, \{M. Vall\} and J. Casabona and N. Rabella and \{De Miniac\}, D. and A. Rod{\'e}s and A. Marco and J. Trabal and C. Trilla",

year = "1995",

month = aug,

day = "1",

doi = "10.1007/BF01690881",

language = "English",

volume = "14",

pages = "710--713",

}

TY - JOUR

T1 - Testing of saliva and serum for HIV in high-risk populations

AU - Mayans, M. Vall

AU - Casabona, J.

AU - Rabella, N.

AU - De Miniac, D.

AU - Rodés, A.

AU - Marco, A.

AU - Trabal, J.

AU - Trilla, C.

PY - 1995/8/1

Y1 - 1995/8/1

N2 - Paired samples of saliva and serum from 286 highrisk subjects were tested for HIV using two commercial enzyme immunoassays following the same WHO testing strategy supplemented with a Western blot technique. Agreement between HIV testing in both sample types was 98.9 % (95 % confidence interval: 97.7-100). The sensitivity of an EIA (Wellcozyme GACELISA) alone for saliva was 100% (133/133) and the specificity 98.7% (151/153). These results support previous data showing that in some situations saliva might be an effective alternative to serum for HIV testing. © 1995 Springer-Verlag.

AB - Paired samples of saliva and serum from 286 highrisk subjects were tested for HIV using two commercial enzyme immunoassays following the same WHO testing strategy supplemented with a Western blot technique. Agreement between HIV testing in both sample types was 98.9 % (95 % confidence interval: 97.7-100). The sensitivity of an EIA (Wellcozyme GACELISA) alone for saliva was 100% (133/133) and the specificity 98.7% (151/153). These results support previous data showing that in some situations saliva might be an effective alternative to serum for HIV testing. © 1995 Springer-Verlag.

UR - https://www.scopus.com/pages/publications/0029091455

U2 - 10.1007/BF01690881

DO - 10.1007/BF01690881

M3 - Article

SN - 0934-9723

VL - 14

SP - 710

EP - 713

JO - European Journal of Clinical Microbiology and Infectious Diseases

JF - European Journal of Clinical Microbiology and Infectious Diseases

ER -

Testing of saliva and serum for HIV in high-risk populations

Resum

SDG de les Nacions Unides

Accés al document

Altres arxius i enllaços

Fingerprint

Com citar-ho